ni2o is a neuroscience and health technology company dedicated to restoring human dignity by treating and ultimately curing debilitating brain disorders. Founded as a spinout from Oxford University and continuing the work initiated by MIT’s Mind Machine Project, ni2o develops AI-powered brain-computer interfaces (BCIs) aimed at addressing the most pressing medical needs of a rapidly aging global population.
At the heart of ni2o’s innovation is KIWI, a minimally invasive brain implant designed to treat neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Unlike traditional deep brain stimulation (DBS) treatments that require extensive surgery, KIWI aims to offer a less invasive solution by using light and electrical impulses to intervene with damaged brain tissue.
ORGANIZATION
ni2o
VALUE OPPORTUNITY
$100 Billion+ USD
MISSION
Cure Brain Disease & Disorder
VISIT WEBSITE
